Delivery Order 75N93018D00010-75N93020F00002
Award Date 5/8/20
Potential Completion Date 5/14/28
Potential Value $21K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Fixed Price Level of Effort
Place of Performance
BOWLING GREEN, NY 10004, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $20,264.00 fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The award is for process development work related to vaccine candidates, including those for SARS-CoV-2. This award appears to be part of a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle that IAVI holds with NIAID for preclinical services supporting...
- This $8,398,301.00 cost-reimbursement delivery order was awarded on December 1, 2021 by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The award is part of NIAID's Preclinical And Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS) program and will support IAVI's preclinical and translational vaccine development work for HIV and other infectious diseases through...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The $55,936.00 cost-plus-fixed-fee contract is a delivery order under IAVI's IDIQ contract with NIAID for preclinical services supporting biopharmaceutical product development and vaccine development for HIV and other infectious diseases. The award...
- This federal contract award, valued at $1,707,175.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract supports process development for cell culture, upstream and downstream processes in the production of HIV-1 biomolecules, as part of NIAID's broader program for process and analytical support in the...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization focused on HIV vaccine development. The $1,098,404.00 cost-plus-fixed-fee contract provides funding for IAVI to perform cell line optimization and pre-master bank generation for SB 301, a vaccine candidate for hepatitis B virus (HBV). This work is being...
- This is a $26,065,720.00 cost-plus-fixed-fee delivery order awarded to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is for the manufacture of human flu challenge material, which supports IAVI's mission to develop safe and effective preventive vaccines for infectious diseases. The award is part of IAVI's existing indefinite...
- This is a $1,327,640.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract is for "COORDINATION AND TECHNICAL SUPPORT" under NIAID's program for "PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES". IAVI, as the prime contractor, will provide a...
- This federal contract award is a Cost Plus Fixed Fee Delivery Order under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The award has a ceiling value of $3,828,720.00 and an ultimate completion date of April 4, 2026. The contract is for the International AIDS Vaccine Initiative (IAVI), a global non-profit organization, to provide a range of research,...
- This federal contract award, valued at $3,170,861.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization focused on the development of HIV vaccines. The contract provides for coordination and technical support services to advance the development of HIV vaccines and other infectious disease products. The contract is a delivery order issued under an Indefinite...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization. The $978,729.00 cost-plus-fixed-fee award supports "ANTIGEN-ADJUVANT FORMULATION AND CHARACTERIZATION STUDIES" as part of NIAID's PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES program. IAVI, the prime contractor, is...